Meeting
2016 Genitourinary Cancers Symposium
Incidence of testosterone escape with LHRH agonists in patients receiving radiotherapy for prostate cancer.
Authors
Derek R Wilke
Department of Radiation Oncology, Dalhousie University, Halifax, NS, Canada
Derek R Wilke , Nikhilesh Gajanan Patil , Helmut Hollenhorst , David Bowes , Robert Rutledge
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 24)
DOI
10.1200/jco.2016.34.2_suppl.24
Abstract #
24
Poster Bd #
B6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Propensity score matched analysis of major adverse cardiac events in patients with localized prostate cancer receiving short term vs long term ADT.
First Author: Ye Yuan
Poster
2019 Genitourinary Cancers Symposium
Prognostic significance of lactate dehydrogenase-5 expression in patients with prostate cancer treated with androgen deprivation therapy and androgen receptor axis-targeted agents.
First Author: Wataru Fukuokaya
Poster
2018 Genitourinary Cancers Symposium
Cardiovascular comorbidities in German prostate cancer patients under androgen deprivation therapy: Results from a retrospective analysis of patient data in urological outpatient centers.
First Author: Andreas Eisenhardt
Poster
2017 Genitourinary Cancers Symposium
Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.
First Author: Abdenour Nabid